✦ LIBER ✦

Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients

✍ Scribed by Gautschi, Oliver; Hugli, Barbara; Ziegler, Annemarie; Bigosch, Colette; Bowers, Naomi L.; Ratschiller, Daniel; Jermann, Monika; Stahel, Rolf A.; Heighway, Jim; Betticher, Daniel C.

Book ID: 119319326
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 163 KB
Volume: 51
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2005.10.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-484 CCND1/Cyclin D1 A870G gene polymor

P-484 CCND1/Cyclin D1 A870G gene polymorphism is associated with non-small cell lung cancer (NSCLC) risk, and affects prognosis and response to chemotherapy

✍ Gautschi, O.; Huegli, B.; Ziegler, A.; Bigosch, C.; Ratschiller, D.; Bowers, N.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Polymorphisms in XRCC1 and XPG and respo

Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients

✍ Sun, Xinchen; Li, Fan; Sun, Ning; Shukui, Qin; Baoan, Chen; Jifeng, Feng; Lu, Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Response to gemcitabine–platinum chemoth

Response to gemcitabine–platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non-small-cell lung cancer

✍ In-Jae Oh; Hee-Jung Ban; Kyu-Sik Kim; Sang-Yun Song; Kook-Joo Na; Yun-Hyeon Kim; 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 163 KB

Predicting response to second-line treat

Predicting response to second-line treatment with TaxotereR (Tax) in patients with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy

✍ Shepherd, F.A; Hammershaimb, L; Kim, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Integrated analysis for two randomized p

Integrated analysis for two randomized phase III studies comparing Taxotere at 75 mg/m2 and 100 mg/m2 to control regimens in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based chemotherapy

✍ Kim, Y.P; Koch, G; Shepherd, F.A; Fossella, F; Hammershaimb, L; Gamza, F; Rodger 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB